Benjamin Derman to Biomarkers, Tumor
This is a "connection" page, showing publications Benjamin Derman has written about Biomarkers, Tumor.
Connection Strength
0.153
-
Clinical applications of mass spectrometry in multiple myeloma. Blood Adv. 2025 Dec 23; 9(24):6593-6603.
Score: 0.121
-
Prognostic Significance of Cell-Free DNA Derived 5-Hydroxymethylcytosine Signatures in Newly Diagnosed Multiple Myeloma. JCO Precis Oncol. 2026 Jul; 10(7):e2501121.
Score: 0.032